Table 1.
Anatomical and functional measurement of all subjects
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | |
|---|---|---|---|---|---|
| BCVA baseline | 20/400 | 20/200 | 20/100 | 20/100 | 20/100 |
| BCVA 6 months | 20/100 | 20/80 | 20/100 | 20/50 | 20/40 |
| Macular sensitivity baseline (dB) | 11.3 | 11.7 | 12.8 | 10.7 | 11.8 |
| Macular sensitivity 6 months (dB) | 15.2 | 21.8 | 16.4 | 14.6 | 13.3 |
| OCT foveal thickness baseline (um) | 474 | 722 | 423 | 321 | 449 |
| OCT foveal thickness 6 months (um) | 371 | 275 | 393 | 215 | 453 |
| FAZ measure—FA baseline (mm2) | 0.22 | 3.77 | 0.32 | 0.98 | 1.47 |
| FAZ measure—FA 6 months (mm2) | 0.12 | 2.08 | 0.41 | 0.99 | 1.54 |
| FAZ measure—OCTA baseline (mm2) | 0.23 | NA | NA | 0.89 | 1.33 |
| FAZ measure—OCTA 6 months (mm2) | 0.25 | NA | NA | 1.03 | 1.42 |
BCVA best correct visaul acuity; OCT optical coherence tomography; FAZ foveal avascular zone; FA: fluorescein angiography; OCTA optical coherence tomography with angiography